Sputnik V Sputnik V COVID-19 vaccine effective against new Coronavirus variants, say developers
Moscow/UNI/Sputnik: Russia’s Sputnik V COVID-19 vaccine is effective against new coronavirus variant, developer Gamaleya Research Center and the Russian Direct Investment Fund (RDIF) said on Monday.
"The Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced strong results of the study on neutralizing activity of sera from individuals vaccinated with Sputnik V vaccine against new variants of SARS-CoV-2," the Gamaleya center and the RDIF said in a press release.
"Vaccination with Sputnik V has produced protective neutralizing titers against new variants, including Alpha B.1.1.7 (first identified in UK), Beta B.1.351 (first identified in South Africa), Gamma P.1 (first identified in Brazil), Delta B.1.617.2 and B.1.617.3 (first identified in India) and Moscow endemic variants B.1.1.141 and B.1.1.317 with mutations in the receptor-binding domain (RBD).rus," it added.
Sputnik V is the only foreign vaccine administered in India so far besides Covishield and Covaxin, which have been developed in the Asian country.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
